ZEB2 and acute lymphoblastic leukemia: Here we report the identification of a recurrent t(2;14)(q22;q32) translocation targeting the human ZEB2 locus in immature/ETP-ALL, indicating that deregulation of ZEB2 expression can act as an initiating driver event for this aggressive disease.